Governance

The SGC is governed by a Board of Directors, composed by representatives of our funders and Scientific Committees which deliberate and provide directions to our research activities.

The SGC Organization is overseen by its CEO Prof. Aled Edwards and each of the SGC labs is directed by a Chief Scientist.

SGC Board


Board of Directors

Board Observers

SGC Management Team

Tetsuyuki Maruyama (Chairman) Dementia Discovery Fund Allison Barr CA Ministry of Research and Innovation Aled Edwards CEO SGC Toronto
Michael Dunn Wellcome Trust   Robert A. Blouin Dean, SOP UNC Paul Van Damme CFO SGC Toronto
Tom Collins (Secretary) Wellcome Trust   Paul Lasko  McGill University Cheryl Arrowsmith CSO SGC Toronto
Saul Rosenberg Abbvie Carlos de Brito Cruz FAPESP Chas Bountra CSO SGC Oxford
Trevor Howe Janssen Cilag UK Kumar Saikatendu Takeda Michael Sundström CSO SGC Karolinska
Spiros Liras Pfizer   Timothy Willson CSO SGC UNC
Adrian J. Carter Boehringer Ingelheim   Jon Elkins CSO SGC Unicamp
Nils Ostermann Novartis   Stefan Knapp CSO SGC Frankfurt
Anke Mueller-Fahrnow Bayer Pharma    Amy Donner Communications  
Ronan O’Hagan Merck    
Stephen Hitchcock Takeda    
Cindy Bell, Genome Canada    

 

Chemical Probes


Scientific Committee

Julian Blagg Institute of Cancer Research, UK
Stephen Burley Rutgers University
Stephen Frye UNC
Paul Thompson University of Massachusetts

 

Joint Management Committee

Alex Shoemaker  Abbvie Anil Vasudevan Abbvie Cora Mund Bayer
Marcus Bauser Bayer Ursula Egner Bayer Guido Boehmelt BI
Laetitia Martin BI Mark Petronczki BI Elizabeth Doherty CHDI
Leticia Toledo-Sherman CHDI Vineet Pande Janssen Benjamin Nicholson Merck
Christian Fischer Merck Ronan O'Hagan Merck Jian Jin MSSM
Dafydd Owen Pfize Mathias Frederiksen Novartis Nils Ostermann Novartis
Zhengtian Yu China-Novartis Sham Nikam Takeda Masayuki Takizawa Takeda
Kumar Saikatendu Takeda Mahindra Makhija Takeda Lindsey Ingerman James UNC

Structure & TEP


Joint Management Committee

 Chas Bountra SGC Vincent Stoll Abbvie   Ursula Egner Bayer
 Neil Farrow Boehringer-Ingelheim Trevor Howe Jansen   Heiko Runz Merck
 Xiayang Qiu Pfizer Ched Grimshaw Takeda   Kirk Clark Novartis
 Nils Ostermann Novartis Daf Owen Pfizer   John Mathias Pfizer
Jayvardhan Pandit Pfizer Russell Judge Abbvie Wei Qiu Abbvie
Ievgeniia Dubrovska Abbvie Lance Bigelow Abbvie Kenton Longenecker Abbvie
Clarissa Jakob Abbvie Chang Park Abbvie Maria Argiriadi Abbvie
Chaohong Sun Abbvie Alex Shoemaker Abbvie Kumar Saikatendu Takeda
Mahindra Makhija Takeda Terry Hughes Jansen Vineet Pande Jansen
Megan Grether Boehringer-Ingelheim Sandra Jacob Novartis Rajiv Chopra Novartis
Carien Dekker Novartis Fai Siu Novartis Veli-Pekka Jaakola Novartis
Cora Mund Bayer    

 

TEP Evaluation Group 

 Mike Ferguson Dundee  Sir Peter Ratcliffe Oxford & Crick Institute Simon Word Sussex
Louise Jones MRC Richard Seabrook Wellcome Ray Parekh Advent Life Sciences
Tim Harrison Queen’s Belfast Jane Endicott Newcastle  

 

Tissue Platforms


Oncology Joint Management Committee 

Erwin Boghaert AbbVie  Bernard Haendler Bayer  Megan Grether BI
 Elizabeth Rex Janssen Mark Bittinger Merck Thomas Paul Pfizer
Kumar Saikatendu Takeda    

 

Inflammation Joint Management Committee

Jesus Paez-Cortez  Abbive Bernard Haendler Bayer Sabine Hoff Bayer
Megan Grether BI Ellen Berg DiscoveRx Matt Mackey Merck
Andreas Katopidis Novartis Perry Hall Pfizer Kumar Saikatendu Takeda

 

Neurobiology Joint Management Committee

 Sophia Blake BI Matthew Kennedy Merck Elizabeth Rex Janssen

 

Target Prioritization Networks


Cancer (TPN)

Paul Workman ICR Ultan McDermott Sanger Timothy Harrison Queens University Belfast
Ashok Venkitaraman MRC Cambridge Donald Ogilvie Manchester Willem Ouwehand Cambridge
Freddie Hamdy Oxford Herbie Newell Newcastle Paul Wyatt Dundee
Margaret Frame Edinburgh Alison Banham Oxford Alex Shoemaker AbbVie
Saul Rosenberg AbbVie Guowei Fang AbbVie Georg Beckmann Bayer
Megan Grether BI Manfred Koegl BI Heiko Runz Merck
Thomas A Paul Pfizer Christopher Claiborne Takeda Chiori Yabuki Takeda
Kumar Saikatendu Takeda Masayuki Takizawa Takeda Hiroshi Miyake Takeda

 

Metabolic disease (TPN)

Steve O'Rahilly  University of Cambridge  Frances Platt Dept of Pharmacology, Oxford Rajesh Thakker OCDEM, Oxford
Ben Davis Dept of Chemistry, Oxford Anna Gloyn OCDEM, Oxford William Newman  Manchester Centre for Genomic Medicine
Peter Clayton Institute of Child Health, London Christine Bulawa Pfizer Steve Pullen  BI
Heiko Runz  Genetics, Merck Yoshiyuki Tsujihata  Takeda Florian Prinz Bayer
Megan Grether  BI Ched Grimshaw  Takeda Georg Beckmann  Bayer

 

Neurobiology (TPN)

Dame Kay Davies Oxford  Zameel Cader Oxford John Geddes Oxford
Jenny Taylor Oxford Mike Owen Cardiff Praveen Anand Imperial
Chris Dobson Cambridge David Reynolds ARUK John Davis ODDI, Oxford
Matthew Hurles Sanger, Cambridge David Collier Lilly Rabinder Prinjha GSK
Bastian Hengerer BI, Biberach Guido Boehmelt BI Ched Grimshaw Takeda 
Takanobu Kuroita Takeda  Kumar Saikatendu Takeda  Shogo Marui Takeda 
Heiko Runz Merck, Genetics Patricio O'Donnell Pfizer Stefan McDonough Pfizer
glqxz9283 sfy39587stf02 mnesdcuix8
sfy39587stf03